NASDAQ$AZTA

Azenta Inc · Q1 2025 earnings

Q1 2025 earnings · · Before market open · Investor relations

Briefing

Reported a strong start to fiscal year 2025 with positive momentum in demand for Sample Management Solutions and Multiomics services.

Azenta reported a 4% year-over-year increase in revenue to $148 million, driven by growth in both Sample Management Solutions and Multiomics. The company's adjusted EBITDA margin improved by 400 basis points year-over-year to 9.0%, and non-GAAP diluted EPS remained flat at $0.08.

  • Revenue increased by 4% year-over-year to $148 million.
  • Sample Management Solutions revenue grew by 3% year-over-year to $81 million.
  • Multiomics revenue increased by 6% year-over-year to $66 million.
  • Adjusted EBITDA margin improved by 400 basis points to 9.0%.

Headline financials

Total Revenue

$148M

Previous: $154M-4.4%
EPS (adj)

$0.08

Previous: -$0.28+128.6%
Adjusted EBITDA margin

9.0%

Previous: 3.0%+200.0%
Organic revenue growth

4.0%

Previous: -15.0%+126.7%
Capital Expenditures

-$8.58M

Previous: -$11.9M+28.0%
Net Income

-$19.6M

Previous: -$15.7M-24.4%
Operating Income

-$11M

Previous: -$26.7M+58.8%
Gross Profit

$68.7M

Previous: $61.5M+11.6%
R&D Expense

$6.38M

No prior period

Revenue & EPS history

Azenta · Revenue · Quarterly

$148M

Q1 2025-4.4%vs Q1 2024
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

The Company is reiterating its revenue guidance for fiscal year 2025.

Tailwinds

  • Total organic revenue is expected to grow in the range of 3% to 5% relative to fiscal 2024.
  • Adjusted EBITDA margin expansion is expected to be approximately 300 basis points relative to fiscal 2024.
  • Focus on cost reduction
  • Focus on productivity improvement
  • Simplifying, standardizing, streamlining, and optimizing the Company’s operations, processes and systems to permanently alter the Company’s operations for the long term.

Headwinds

  • Volatility of the life sciences markets the Company serves.
  • Possible inability to meet demand for our products due to difficulties in obtaining components and materials from our suppliers in required quantities and of required quality.
  • The inability of customers to make payments to us when due.
  • Price competition.
  • Disputes concerning intellectual property.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

-0.6%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+0.4%

Avg return

30 days after

43%

28 / 65 earnings

Positive

+22.4%

Q4 2025

Best reaction

-23.4%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-21.6%-21.0%-6.1%
Q1 2026-23.4%-19.3%-34.2%
Q4 2025+22.4%+20.9%+14.8%
Q2 2025-0.7%+11.3%+13.1%
Q1 2025+3.4%-8.6%-16.0%
Q4 2024-2.9%-9.4%+0.2%
Q3 2024-4.9%-1.1%-15.4%
Q2 2024-4.8%-6.9%-2.1%
Q1 2024-4.0%-1.2%-2.0%
Q4 2023+14.6%+16.1%+27.2%
Q3 2023+21.8%+18.4%+11.0%
Q2 2023-19.8%-11.1%+0.0%
Q1 2023-20.8%-22.2%-29.7%
Q4 2022+15.8%+17.5%+25.8%
Q3 2022-10.3%-8.7%-23.8%
Q2 2022-4.0%+5.6%+8.9%
Q1 2022+5.6%-3.1%-7.0%
Q4 2021-7.6%-7.1%-16.7%
Q3 2021-4.0%-4.0%-3.5%
Q2 2021-7.3%-7.1%-2.9%
Q1 2021-2.8%-0.3%-4.2%
Q4 2020+9.7%+12.8%+19.9%
Q3 2020+17.8%+21.2%+13.2%
Q2 2020-15.4%-12.3%-3.9%
Q1 2020-1.4%+6.7%-15.1%
Q4 2019+7.8%+5.5%-7.7%
Q3 2019-15.7%-17.0%-14.1%
Q2 2019+18.5%+23.4%+15.6%
Q1 2019+0.9%-5.3%-0.4%
Q4 2018-11.6%-10.9%-13.6%
Q3 2018-7.2%-5.8%+22.3%
Q2 2018+8.4%+12.5%+31.4%
Q1 2018-3.4%-9.5%-2.4%
Q4 2017-23.3%-21.2%-28.8%
Q3 2017-8.1%+0.9%+6.6%
Q2 2017+6.0%+9.4%+16.3%
Q1 2017+16.9%+20.6%+20.0%
Q4 2016+7.7%+11.7%+20.1%
Q3 2016-3.3%-5.4%-1.7%
Q2 2016-7.3%
Q1 2016-1.7%
Q4 2015-0.2%
Q3 2015+11.2%
Q2 2015-0.5%
Q1 2015-5.1%
Q4 2014+6.0%
Q3 2014+2.7%
Q2 2014+1.1%
Q1 2014-1.3%
Q4 2013+2.9%
Q3 2013-4.0%
Q2 2013+2.7%
Q1 2013+2.5%
Q4 2012+1.3%
Q3 2012-13.8%
Q2 2012-1.1%
Q1 2011+7.2%
Q1 2012+7.2%
Q4 2009+2.8%
Q2 2011+2.8%
Q4 2011+2.8%
Q4 2010-0.1%
Q3 2010-0.1%
Q3 2011-0.1%
Q2 2010-6.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro